The global sales of stent graft balloon catheters are estimated to be worth USD 1,047.9 million in 2025 and are anticipated to reach a value of USD 2,194.9 million by 2035. Sales are projected to rise at a CAGR of 6.8% over the forecast period between 2025 and 2035. The revenue generated by stent graft balloon catheter in 2024 was USD 981.1 million.
The sales of stent graft balloon catheters show the gradual development with time regarding improvement in the minimally invasive procedure arena, hence escalating demand as need for the efficient management and treatment of vascular disorder is growing rapidly.
The combined balloon angioplasty and placement of the stent graft balloons treat even such severe indications, such as the aortic aneurysm and peripheral artery diseases. These devices enable very accurate dilation and strengthening of the blood vessels; complicated vascular issues are frequently solved effectively and for a long period.
A major influencer for market growth has been the continued technological advances being developed for the stent graft balloon catheter. Newer versions of catheters provide better mechanisms for inflation of the balloon to ensure effective dilation of vessels, and with the advent of improved biocompatibility materials, the durability of the devices is increased, and complications are kept at a minimum.
Global Stent Graft Balloon Catheter Industry Analysis
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 981.1 million |
| Estimated Size, 2025 | USD 1,047.9 million |
| Projected Size, 2035 | USD 2,194.9 million |
| Value-based CAGR (2025 to 2035) | 6.8% |
The increasing trend of endovascular procedures, especially in regions like North America and Europe, is further boosting market growth. The prevalence of chronic vascular conditions has increased, and the demand for precise, minimally invasive solutions for improving patient outcomes has increased the preference for stent graft balloon catheters among healthcare providers. The market also continues to see growth in outpatient procedures, as these promise less invasive interventions and quicker recovery times compared to traditional open surgeries.
The market for stent graft balloon catheters is anticipated to maintain its positive growth with increasing awareness regarding the advantages of minimally invasive treatments and a rise in focus towards cost-effective healthcare.
Catheter technology innovations, in addition to expanding their use for a wider array of vascular interventions, place these devices at the center of modern vascular care, particularly in the growth markets of the Asia-Pacific and Latin America, where health systems increasingly focus on sophisticated nonsurgical treatments.
The focus of the manufacturers has hence shifted toward developing new-generation stent graft balloon catheters with better safety parameters, better precision, and yielding better long-term outcomes. These promising improvements, together with growth in non-invasive procedures, will shape the vascular treatments of the future and offer stent graft balloon catheters as their mainstay of modern healthcare medicine.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
A comparative analysis of fluctuations in compound annual growth rate (CAGR) for the stent graft balloon catheter industry outlook between 2024 and 2025 on a six-month basis is shown below.
By this examination, major variations in the performance of these markets are brought to light, and trends of revenue generation are captured hence offering stakeholders useful ideas on how to carry on with the market’s growth path in any other given year. January through June covers the first part of the year called half1 (H1), while half2 (H2) represents July to December.
The table below compares the compound annual growth rate (CAGR) for the global stent graft balloon catheter industry analysis from 2024 to 2025 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics. H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 7.5%, followed by a slightly lower growth rate of 7.2% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 7.5% (2024 to 2034) |
| H2 | 7.2% (2024 to 2034) |
| H1 | 6.8% (2025 to 2035) |
| H2 | 6.3% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 6.8% in the first half and projected to lower at 6.3% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Expanding Role of Stent Graft Balloon Catheters in Vascular Interventions Strengthens Market Growth
The rising role of these stents in complex vascular interventions has led to significant growth in the stent graft balloon catheter market. Attraction toward endovascular procedures for chronic vascular diseases is on the rise, which has driven the adoption of stent graft balloon catheters.
Such catheters combines balloon angioplasty accuracy with the stent graft's stability, granting immense delicacy in the management of blockage and weakness in every blood vessel type. The fact that stent graft balloon catheters will be able to treat high-risk patients who have small or no possibility of successful treatment with standard methods has been of great significance toward market growth. These devices have also become part of the trend toward minimally invasive treatments associated with reduced recovery times, complications, and costs for patients.
As these continue to be key solutions among medical professionals, the market for stent graft balloon catheters will see further expansion. This, in turn, underlines their key role within modern vascular care and continues to strengthen the course of market growth in subsequent years.
Increasing Demand for Minimally Invasive Vascular Procedures Fuels Stent Graft Balloon Catheter Adoption
The demand for the minimally invasive procedures in healthcare industry can be considered one of the main factors that pushes stent graft balloon catheter requirements forward. Such a factor leads to greater preference and use of devices by patients and medical care professionals instead of going into the operations to treat conditions affecting blood circulation.
The main advantages of such minimally invasive treatments are less hospitalization time, quick recovery, less chance of infection, and lower treatment cost compared to traditional open surgeries. Stent graft balloon catheters are therefore increasingly being considered and adopted in most healthcare systems across North America and Europe for conducting such procedures.
These devices enable very accurate treatment of vascular pathologies with minimal trauma of the surrounding tissues and, as such, constitute the best option for high-risk patients who cannot be treated conventionally.
This factor along with increasing awareness of the benefits associated with minimally invasive treatments is likely to continue driving demand for stent graft balloon catheters in their current upward direction and further solidify their position in contemporary vascular interventions.
Technological Advancements and Innovation Drive Stent Graft Balloon Catheter Market Growth
In recent years, technologically innovative designs of stent graft balloon catheters are seen to have triggered their sale significantly. Several important improvements in catheter technologies within the past few years have collectively enhanced performance of the devices, thus fostering a wide usage in clinics and hospitals.
This is through developing the design of balloon catheters, where manufacturers incorporate high-strength material with structures that can be more flexible in negotiating complex vascular systems. Besides, other innovative products, such as drug-eluting stent grafts releasing therapeutic agents to impede restenosis, extend the clinical applications of these devices. The mechanism of inflation of the balloon has also been optimized to result in more controlled and uniform vessel dilation; this reduces the chances of complications that may arise from the procedures.
Furthermore, advanced imaging technologies, such as real-time 3D imaging, allow for accurate stent graft balloon catheter placements, thus enhancing the success rates of procedures. This, together with better patient outcomes, is driving continued adoption. The market will continue to witness growth as manufacturers focus on next-generation solutions, placing stent graft balloon catheters among the major tools in vascular care.
Increasing Competition and Pricing Pressure Hinders the Stent Graft Balloon Catheter Market
The leading challenge in the stent graft balloon catheter market is growing competition and related pricing pressure. As the market continues to grow, various companies are entering into the competition, offering a set of different types of stent graft balloon catheters with variant features and specifications. This fills the race with upward innovation but puts downward pressure on the pricing of such devices, especially for those highly competitive markets of North America and Europe.
This has forced the prices down in order to keep the competition levels, and this hurts the profitability of the manufacturers. Increased producers also mean variable qualities of products on the market. While the current competition is encouraging technological advancements and increasing product differentiation, the challenge today is how these products can be afforded yet still be produced at high quality.
The companies need continuous innovation, improvement in manufacturing efficiency, and conformity with strict regulatory standards to remain competitive. Most important, regulatory requirements differ significantly regarding the pricing across different regions, making new market entry even more complex.
The global stent graft balloon catheter industry recorded a CAGR of 3.5% during the historical period between 2020 and 2024. The growth of the stent graft balloon catheter industry was positive as it reached a value of USD 981.1 million in 2024 from USD 852.9 million in 2020.
The growth of the sales of stent graft balloon catheter is continuous and steady. Growth was due to new innovations in minimally invasive vascular treatments. Rising number of patients with vascular disease are preferring to the quick treatment procedures along with shorter hospital stays.
These devices, which combine balloon angioplasty with stent graft placement, offer less invasive alternatives to conventional surgery and, thus, make the periods of recovery shorter and complication rates lower. As the healthcare system focuses on inexpensive and efficient methods of treatment, the use of endovascular procedures has increased.
The significant advancements made in this period include high-performance materials for stents, improved balloon inflation technology, and incorporation of sophisticated imaging tools like real-time fluoroscopy that significantly enhanced the precision and efficiency of the procedures.
In the coming future, markets are going to reshape themselves by taking in new emerging technologies, artificial intelligence, and machine learning, among others. It will enable real-time decision support, thereby leading to more precise device placement and highly customized treatment planning. The improvement of automation in complex endovascular procedures, especially with regard to areas of aortic repairs and peripheral vascular interventions, would further push the treatment outcome to a new level.
With the growing interest in personalized medicine, there is an enormous need for more sophisticated stent graft balloon catheters, especially the drug-eluting one that might be able to prevent restenosis. The market is further likely to diversify in the coming years, expecting to find a new wave of applications in regenerative medicine and pain management. The growth is expected to be strong for the market because the demand for minimally invasive solution continues to grow rapidly around the world, owing to continued innovations, improved procedural techniques, and a growing patient preference for less invasive intervention.
Tier 1 companies are the major companies as they hold a 39.7% share worldwide. These focus on extensive product portfolios, continuous R&D investments, and technological leadership. They emphasize innovation in catheter materials, balloon expansion control, and precision for complex vascular procedures while maintaining a global market presence and strong distribution channels.
These companies often secure regulatory approvals swiftly and engage in strategic collaborations for market expansion. Prominent tier 1 players include Medtronic, Boston Scientific, Abbott Laboratories and Cordis
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a share of 26.2% worldwide. These Tier 2 manufacturers prioritize regional market penetration and cost-effective solutions. Their focus lies on balancing quality with affordability, catering to emerging markets, and addressing niche procedural demands.
Tier 2 players often invest in incremental innovations rather than breakthrough technologies, focusing on expanding their market footprint through competitive pricing and strategic partnerships. Key Companies under this category include Atrium Medical, W. L. Gore & Associates Inc., Terumo Corporation and Cook Medical.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the industry analysis for stent graft balloon catheter sales for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East & Africa is provided. The United States is anticipated to remain at the forefront in North America, with a CAGR of 2.9% through 2035. In South Asia & Pacific, India is projected to witness the highest CAGR in the market of 9.2% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 2.9% |
| Germany | 2.5% |
| Italy | 3.2% |
| UK | 5.8% |
| India | 9.2% |
| China | 8.5% |
The United States dominates the global market with a high share in 2024. The United States is expected to exhibit a CAGR of 2.9% throughout the forecast period (2025 to 2035).
With the high incidence rate of vascular diseases, market leaders have always focused on the United States to develop the advanced products in this region. It is due to the high demand and affordability of the people in the USA As the trendsetter in the healthcare industry, the United States takes an advantage of the most advanced medical technology, research, and support for minimally invasive treatment applications.
An aging population is one of the major drivers of this market, which significantly contributes to the demand for vascular interventions. Due to increasing awareness among patients regarding more minimally invasive procedures, short recovery times, and fewer complications from minimally invasive surgeries compared to surgical alternatives, stent graft balloon catheters have also gained popularity in the market.
The United States government is also actively supporting health technology and reimbursement policies that are more favorable incentives towards endovascular treatments, hence driving the growth of the market. There is also a high volume of clinical trials along with a strong presence of leading manufacturers in medical devices, keeping maintaining a pipeline of innovation for stent graft technology.
In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 2.5%.
Germany's focus on precision medicine and established endovascular surgery programs, it has now become one of the prime markets for stent graft balloon catheters. Given its solid infrastructure and very well-trained healthcare professionals, Germany is leading in the adoption of advanced medical technology for vascular intervention.
A prime example is in the increased adoption of stent graft balloon catheters due to the focus by the country on precision medicine where treatment is made patient-specific, such as managing aortic aneurysm and peripheral artery disease. Increased success and accuracy rates of these procedures are due to state-of-the-art imaging technologies presently used, such as real-time 3D fluoroscopy and intravascular ultrasound.
Germany's well-funded healthcare system, with a keen interest to reduce procedural risks and to improve the patient outcome, promotes these minimally invasive treatments on an increased scale. Additionally, beneficial reimbursement policies along with a favorable regulatory environment created by the government has helped the entry of new products into the markets in the domain of medical devices.
India occupies a leading value share in South Asia & Pacific market in 2024 and is expected to grow with a CAGR of 9.2% during the forecasted period.
India is emerging as an increasingly important growth driver for the stent graft balloon catheter market, given the country's rapidly escalating rates of CVDs, which include aortic aneurysms and PAD.
With the increasing incidence of these chronic disorders, especially within the aging group and those that have risk factors of diabetes and hypertension, the growing demand for efficacious and minimal invasive vascular intervention has been greatly on the surge. Stent graft balloon catheters are adopted more and more in treating complex conditions of the vessels because they tend to offer selective, effective care with fewer complication rates and the possibility of lesser recovery time following the procedure.
The growing burden of cardiovascular diseases and the change in patient preference to less invasive procedures have necessitated the increasing demand for these devices within hospitals and clinics across the country. Besides, the development of specialized centers for cardiac and vascular care within India's healthcare system improves access to advanced treatments. This is where the rising cardiovascular disease rates and the expansion of access to healthcare are positioning India as a key market for stent graft balloon catheters.
The section contains information about the leading segments in the industry. Based on product, non-compliant balloon stent catheter are expected to account 63.5% of the global share in 2025.
| Product | Non-Compliant Balloon Stent Catheter |
|---|---|
| Value Share (2025) | 63.5% |
Non-compliant balloon stent catheters represent the most prominent product in the stent graft balloon catheter market. These catheters are engineered to provide more pressure dilation. They are ideal for treating vascular conditions that require more robust performance, such as aortic aneurysms and peripheral artery disease (PAD). Their non-compliant nature allows these to maintain their size upon inflation, giving the stent a precise and controlled expansion, which is critical for critical vascular interventions.
These catheters gained popularity because they are versatile and reliable with great performance to obtain optimal results. Moreover, breakthroughs in technology of balloon material have improved durability and efficiency that has contributed the use of the non-compliant balloon stent catheter in even the most challenging vascular procedures; hence, continue to lead in the industry with high pressure operations and delicate procedures for stent deployment.
| By End User | Hospitals |
|---|---|
| Value Share (2025) | 36.4% |
Hospitals will account for 36.4% of the end user segment in 2025, and exhibit the highest CAGR in the forecast period.
Hospitals are leading end-users for stent graft balloon catheter due to more infrastructure, professionals, and other patient care in hospitals. Of all the settings, large hospitals and specialized cardiology centers use a significant quantity of endovascular procedures due to vascular disease such as PAD, aortic aneurysm, or coronary artery diseases. They have state-of-the-art diagnostic tools, surgical theaters, and post-procedure care; therefore, it is the best place for conducting stent graft balloon catheter procedures.
Besides, hospitals provide emergency care in case of an accident and therefore are the best choice for patients with complex and risky vascular interventions. The shift to minimally invasive surgeries is also supported by hospitals since the latest stent graft balloon catheters are now more commonly used to improve the patient's outcomes and shorten the recovery time.
Key players in this market are focusing on securing FDA approvals to accelerate product launches and gain a competitive edge. Partnerships with healthcare institutions and research organizations are being leveraged to drive innovation in catheter technology and expand applications in complex vascular procedures. Additionally, manufacturers are emphasizing product differentiation through advanced materials and precision engineering to meet the growing demand for minimally invasive treatments.
Recent Industry Developments in Stent Graft Balloon Catheter Market
In terms of product, the industry is divided into non-complaint balloon stents catheter and complaint balloon stents catheter.
In terms of end user, the industry is segregated into hospitals, cardiac centers and ambulatory surgical centers.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East and Africa (MEA) have been covered in the report.
The global stent graft balloon catheter industry is projected to witness CAGR of 6.8% between 2025 and 2035.
The global stent graft balloon catheter industry stood at USD 981.1 million in 2024.
The global stent graft balloon catheter industry is anticipated to reach USD 2,194.9 million by 2035 end.
China is expected to show a CAGR of 8.5% in the assessment period.
The key players operating in the global stent graft balloon catheter industry include Medtronic, Boston Scientific, Abbott Laboratories, Cordis, Atrium Medical, W. L. Gore & Associates Inc., JOTEC GmbH, QXMédical, LLC, Terumo Corporation, Cook Medical and Others.
| Estimated Size, 2024 | USD 2,861.0 million |
|---|---|
| Projected Size, 2034 | USD 5,436.8 million |
| Value-based CAGR (2024 to 2034) | 6.6% |
| Market Estimated Size in 2023 | USD 585.6 million |
|---|---|
| Projected Market Value in 2033 | USD 1,058.6 million |
| Value-based CAGR from 2023 to 2033 | 6.1% |
| Market Size (2023) | USD 4.2 Billion |
|---|---|
| Market Size (2033) | USD 6.4 Billion |
| Market CAGR (2023 to 2033) | 4.3% |
| Radiofrequency Balloon Catheter Market Size (2022) | USD 50 Billion |
|---|---|
| Radiofrequency Balloon Catheter Market Projected Growth Rate (2022 to 2032) | 5.5% |
Explore Therapeutic Device Insights
View Reports
Stent Graft Balloon Catheter Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
